Becker's Healthcare October 6, 2023
Walmart is experiencing less food demand from individuals taking GLP-1s such as Ozempic or Wegovy, Bloomberg reported Oct. 4.
“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” Walmart U.S. CEO John Furner told the publication. “Just less units, slightly less calories.”
According to the report, Walmart and some food manufacturers are...